Revertant Mosaicism Obscures Long‐Awaited Molecular Confirmation of Diamond‐Blackfan Anemia
American Journal of Medical Genetics Part A, Volume 200, Issue 10, Page 2381-2383, October 2026.
Nicholas A. Borja, Mustafa Tekin
wiley +1 more source
In vivo effects of curcumin and deferoxamine in experimental endometriosis
, 2017 Background. Endometriosis is one of the most common chronic gynecological diseases. Objectives. The aim of the study was to examine the effects of curcumin and/or deferoxamine on cell proliferation in a rat model of endometriosis.
Uz, Yesim Hulya +6 more
core +1 more source
Journal of Inflammation ResearchYanlin Zhu,1,2 Shuwei Qiao,2,3 Yuxuan Pang,2,3 Huimin Wang,2,3 Yanmin Zhou1,2 1Department of Dental Implantology, Hospital of Stomatology, Jilin University, Changchun, People’s Republic of China; 2Jilin Provincial Key Laboratory of Tooth Development and ...
Zhu Y, Qiao S, Pang Y, Wang H, Zhou Y
doaj
The effect of intravenous Deferoxamine during blood transfusion time in thalassemia major patients [PDF]
CONTEXT AND OBJCTIVE: Subcutaneous Deferoxamine intolerance by patients and reject its use Cause to iron overload and its complications. So, uses other methods with easier tolerate and reduce Deferoxamine consumption is necessary.
فتحی, افشین +1 more
core
Comparative Efficacy of Deferiprone, Deferoxamine and Combination of Deferiprone and Deferoxamine on Serum Ferritin Value in Beta-Thalassemia Patients [PDF]
, 2015 Background: Iron overload is a predictable and lifethreatening complication in patients with thalassemia. Effective and convenient iron chelation remains one of the main targets of clinical management of thalassemia major.
Haniye Mohsenkhah Amlashi +7 more
core +1 more source
Haematologica, 2003 BACKGROUND AND OBJECTIVES: Iron-induced cardiac disease remains the main cause of death in patients with thalassemia major, despite chelation therapy with deferoxamine.
A Piga +3 more
doaj
Haematologica, 2006 An expert group of the International Committee on Oral Chelators (ICOC) has recommended a universally effective chelation combination protocol of oral deferiprone (L1) during the day (80-110 mg/kg /day) and subcutaneous deferoxamine (40-60 mg/kg) of a ...
GJ Kontoghiorghes, A Kolnagou
doaj
Effect of intravenous Deferoxamine concomitant use with blood transfusion on serum ferritin in thalassemia major patients [PDF]
Background: Subcutaneous Deferoxamineis often not tolerated by patients and its rejection leads to iron overload with its complications. So, other methods with better toleration and reduction of Deferoxamine consumption are necessary. The present study
عرقچین, سمیرا +3 more
core
The impact of intravenous deferoxamine during the blood transfusion on reduction of serum ferritin in thalassemia patients [PDF]
Introduction: A blood transfusion in patients with thalassemia major is a important treatment base. Iron overload resulted from Long-term transfusion-related using iron chelators particularly by the deferoxamine can be reduced.
عرقچین, سمیرا +2 more
core
Liver iron concentration and renal dysfunction in β-thalassemia: a case series and exploratory clinical observations. [PDF]
Ann HematolKabbara F +8 more
europepmc +1 more source